15th Annual Scientific Meeting
Question 1: Are patients with any degree of suicidality acceptable for inclusion in clinical trials?
Chair: Carla Canuso
Question 2: Are acute rapid onset anti-depressant results valid, or just a consequence of functional unblinding?
Chair: Stephen Brannan
Disease Modification: Untangling and Resolving the Complex Challenges of Delayed-Start Designs
Chairs: Larry Alphs/Luca Pani
Methodological issues associated with the new Alzheimer’s Draft Guidance
Chairs: Adam Butler/Judy Jaeger
Finding the Signal: Strategies for achieving participant-centric trials in the face of participant-introduced validity challenges
Chairs: Sian Ratcliffe/Tim Mariano/Kari Nations
The Perils and Promise of Real-World Outcomes in Clinical Trials
Chairs: Dawn Velligan/Rob Epstein
Poster Session (Guidelines and Submission Form)